Source: International Congress 2015 – Acute critical care: news from the ICU
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Antoni Torres Marti (Barcelona, Spain), Antoni Torres, Oriol Sibila, Miquel Ferrer, Rosario Mendendez, Josep Mensa, Albert Gabarrus, Jacobo Sellares, Marcos Restrepo, Antonio Anzueto, Nichael Niederman, Carlos Agusti, Eva Polverino. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: A randomized clinical trial. Eur Respir J 2015; 46: Suppl. 59, 3267

Member's Comments

No comment yet.

Related content which might interest you: Does previous warfarin treatment effect complications and outcome in hospitalised patients with community-acquired pneumonia? Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Adjunctive treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired pneumonia: a randomised clinical trial Source: Eur Respir J, 58 (2) 2002535; 10.1183/13993003.02535-2020 Year: 2021 Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 LATE-BREAKING ABSTRACT: Intravenous infusion of Chinese medicine xuebijing significantly improved clinical outcome in severe pneumonia patients in a multiple center randomized controlled clinical trials Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies Year: 2016 Late Breaking Abstract - Adjunctive treatment with oral dexamethasone in adults hospitalised with community-acquired pneumonia: a randomised clinical trial Source: Virtual Congress 2020 – ALERT: Infection in adults and children Year: 2020 Effectiveness of immune stimulatory therapy in patient with severe community-acquired pneumonia (CAP) Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014 Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections Year: 2009 Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia Source: Eur Respir J 2009; 33: 153-159 Year: 2009 Increasing outpatient treatment of mild community-acquired pneumonia: systematic review and meta-analysis Source: Eur Respir J 2011; 37: 858-864 Year: 2011 Clinical stability and switch therapy in hospitalised patients with community-acquired pneumonia: are we there yet? Source: Eur Respir J 2013; 41: 5-6 Year: 2013 Effects of using the 2007 IDSA/ATS minor criteria to manage severe community-acquired pneumonia Source: Annual Congress 2013 –Recent developments in pneumonia Year: 2013 Tofacitinib versus standard of care treatment in patients with COVID-19 pneumonia and respiratory failure: a multicenter cohort study Source: Virtual Congress 2021 – Acute COVID - 19 Year: 2021 An unbalanced inflammatory response on admission impacts clinical stability in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Prior antibiotics and outcomes in patients hospitalized with pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 Clinical and laboratory predictors of survival in patients with severe community-acquired pneumonia (CAP) Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 "Masks" of severe pneumonia (retrospective analysis of letal severe community-acquired pneumonia (sCAP)) Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment Year: 2013 Differential characteristics of patients with mild acute respiratory distress syndrome due to community-acquired pneumonia admitted to ICU Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia Year: 2013 The effect of pre-hospital anti-platelet therapy in adults with ARDS: A meta-analysis Source: International Congress 2016 – Sepsis and ARDS: looking forward Year: 2016 Out-patient combination therapy with inhaled corticosteroids and bronchodilators is associated with lower in-hospital mortality in pneumonia in patient with COPD Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016 Effect of de-escalation antibiotic therapy on hospital-acquired, ventilator associated, and healthcare-associated pneumonia: A systematic review and meta-analysis Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections Year: 2016